DyeVert™ PLUS

Proven Contrast Reduction with Uncompromised Imaging

DyeVert™ PLUS Contrast Reduction System is a dye management solution for patients with at-risk kidney factors, including:

Heart icon
Moderate and severe chronic kidney disease

Heart icon
Diabetes

Heart icon
Older age

Heart icon
Heart failure

Dye reduction

DyeVert™ PLUS is the only FDA cleared product with the claim of reduced dye delivery to the patient without impacting image quality.

Proven results

DyeVert™ PLUS clinical results show over 40% average reduction in contrast dosage injected to the patient.1

Real-time dose monitoring

DyeVert™ PLUS module, smart-syringe and monitor wirelessly communicate real-time contrast monitoring throughout each procedure.

1 Desch, S. et all. Impact of a novel contrast reduction system on contrast savings in coronary angiography – The DyeVert randomized controlled trial. Int J Cardiol (2018) https://doi.org/10.1016/j.ijcard.2017.12.107

Indications, contraindications, warnings, and instructions for use can be found in the product labeling supplied with each device. Risks may include air emboli and infection.
CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician.

Uncompromised Imaging: Seeing is Believing

Injections into coronary arteries may result in excess reflux into the aorta that is not needed for imaging. DyeVert™ PLUS reduces contrast amount without compromising image quality. See for yourself.

Without contrast reduction

Contrast reflux leads to increased, unnecessary volume usage

With DyeVert™ Plus contrast reduction

reduced contrast reflux leads to decreased volume usage
Real-Time Monitoring

Real-Time Monitoring

Optimizing procedures for coronary angiography patients at-risk for kidney injury starts with DyeVert™ PLUS technology.

DyeVert Plus™

The DyeVert Plus Technology

DyeVert™ PLUS contrast reduction system is easy to use and incorporate into common cath-lab procedures.